Aurobindo Pharma has reported results for third quarter ended December 31, 2013.
The company has reported over two fold jump in its net profit at Rs 418.16 crore for the quarter as compared to Rs 144.28 crore for the same quarter in the previous year. Total income of the company increased by 33.41% at Rs 1911.08 crore for quarter under review as compared to Rs 1432.45 crore for the quarter ended December 31, 2012.
On the consolidated basis, the group has reported over four fold jump in its net profit after taxes and Minority Interest at Rs 417.49 crore for the quarter as compared to Rs 91.81 crore for the same quarter in the previous year. Total income of the group has increased by 36.07% at Rs 2144.12 crore for quarter under review as compared to Rs 1575.73 crore for the quarter ended December 31, 2012.
